2-piperidone has been researched along with Leukemia P388 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, TM; Balzarini, J; De Clercq, E; Dimmock, JR; Jha, A; Manavathu, EK; Santos, CL; Selvakumar, P; Sharma, RK; Shrivastav, A; Stables, JP; Zello, GA | 1 |
Arora, VK; Dimmock, JR; Fang, WD; Hamon, NW; Jia, Z; Lee, JS; Quail, JW; Warrington, RC; Wonko, SL | 1 |
2 other study(ies) available for 2-piperidone and Leukemia P388
Article | Year |
---|---|
3,5-bis(phenylmethylene)-1-(N-arylmaleamoyl)-4-piperidones: a novel group of cytotoxic agents.
Topics: Animals; Anticonvulsants; Antifungal Agents; Antineoplastic Agents; Cell Line, Tumor; Leukemia L1210; Leukemia P388; Leukemia, T-Cell; Mice; Piperidones; T-Lymphocytes | 2003 |
3,5-Bis-benzylidene-4-piperidones and related compounds with high activity towards P388 leukemia cells.
Topics: Animals; Antineoplastic Agents; Benzylidene Compounds; Cell Survival; DNA, Neoplasm; Glutathione; Leukemia P388; Liver; Maleates; Mice; Mice, Inbred Strains; Molecular Conformation; Nucleic Acid Denaturation; Piperidones; Structure-Activity Relationship; Tumor Cells, Cultured; X-Ray Diffraction | 1990 |